obesity drug news today glp-1 october 2025 Alarming rise in weight loss overdoses Study identifies benefits, risks linked
Description
JAMA Intern Med 2022
The administration of dulaglutide reduced cardiac remodelling in rodent HF models
The same study found that 66% of those taking tirzepatide lost 10% or more of their initial weight, while only 41.1% of the semaglutide group did
UpToDate website
Addiction treatment centers are already prescribing GLP-1 medicines to patients While clinical trials continue, some major addiction treatment facilities, or at least one, arent waiting for the final verdict on GLP-1 medications
